ArticleGut2008

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.

D A Vallera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.